It is adamantly opposed by critics aligned with the pharmaceutical industry who liken it to socialism. The Trump administration disputes that and says its rule could potentially result in 30% savings for patients. It also would allow private insurance plans for workers and their families to get Medicare's lower prices. Trump has taken other action to lower prescription drug costs by opening a legal path for importing medicines from abroad. Also, Medicare drug plans that cap insulin costs at $35 a month are available during open enrollment, currently underway.